INVO Fertility (IVF) Operating Margin Growth (3y) (2014 - 2025)
INVO Fertility (IVF) Operating Margin Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -283.00 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -184.00 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,016.00 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 1,505.00 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -3,846.00 |
| 10 | INVO Fertility | 5.10 Mn | 4.75 Mn | 629,345.00 | 98,010.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 98,010.00 |
| Jun 30, 2025 | 167,472.00 |
| Mar 31, 2025 | 61,619.00 |
| Dec 31, 2024 | 2,027.00 |
| Sep 30, 2024 | 94,809.00 |
| Jun 30, 2024 | 80,406.00 |
| Mar 31, 2024 | 13,220.00 |
| Dec 31, 2023 | 80,029.00 |
| Sep 30, 2023 | 28,632.00 |
| Jun 30, 2023 | -22,204.00 |
| Mar 31, 2023 | -12,263.00 |
| Dec 31, 2022 | 227,674.00 |
| Sep 30, 2022 | -86,487.00 |
| Jun 30, 2022 | -182,518.00 |
| Mar 31, 2022 | -147,682.00 |
| Dec 31, 2021 | 47,419.00 |
| Sep 30, 2021 | -88,697.00 |
| Jun 30, 2021 | 71,963.00 |
| Mar 31, 2021 | -9,316.00 |
| Dec 31, 2020 | -66,731.00 |